CLINICAL TRIALS PROFILE FOR MGL-3196
✉ Email this page to a colleague
Clinical Trials for MGL-3196
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02542969 ↗ | Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin | Completed | Celerion | Phase 1 | The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of child-bearing potential. |
NCT02542969 ↗ | Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin | Completed | Madrigal Pharmaceuticals, Inc. | Phase 1 | The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of child-bearing potential. |
NCT02749578 ↗ | Drug Interaction Study of MGL-3196 With Atorvastatin | Completed | Celerion | Phase 1 | The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of atorvastatin in healthy male subjects and female subjects not of child-bearing potential. |
NCT02749578 ↗ | Drug Interaction Study of MGL-3196 With Atorvastatin | Completed | Madrigal Pharmaceuticals, Inc. | Phase 1 | The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of atorvastatin in healthy male subjects and female subjects not of child-bearing potential. |
NCT02912260 ↗ | Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH) | Unknown status | Madrigal Pharmaceuticals, Inc. | Phase 2 | The primary objective of this study is to determine the effect of once-daily oral MGL-3196 on the percent change in hepatic fat fraction from baseline in patients with biopsy-proven Non-alcoholic Steatohepatitis (NASH). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for MGL-3196
Condition Name
Clinical Trial Locations for MGL-3196
Trials by Country
Clinical Trial Progress for MGL-3196
Clinical Trial Phase
Clinical Trial Sponsors for MGL-3196
Sponsor Name